With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin ...

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said in an interview.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

China’s Ambassador to Nigeria, Yu Dunhai, disclosed plans by Chinese companies to establish a local insulin production facility in Nigeria. Yu said when completed, it would end Nigeria’s dependence on ...

Nigeria is set to host Africa's first local insulin production facility, a project expected to lower treatment costs, expand access to life-saving diabetes medication, and position the country as a ...

Discover why LLY stock is rated Buy as sales surge in diabetes & obesity drugs and new treatments drive future growth.

A bill that would cap the price of insulin in California at $35 for a 30-day supply has been approved by the state legislature and is heading to Gov. Gavin Newsom's desk. Senate Bill 40 by State Sen.

SYDNEY—Fitch Ratings has nudged up its world growth outlook for 2025 despite growing gloom about the U.S. economic outlook, saying China and Europe aren’t as downbeat as earlier thought. There is now ...

CrowdStrike turned in generally lackluster quarterly results. However, its prediction that ARR growth would accelerate to 40% excited investors. That said, given its valuation, much of this optimism ...